Diversified Healthcare Trust (DHC) Stock Price, News & Analysis

Company Overview

DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of December 31, 2023, DHC's approximately $7.2 billion portfolio included 371 properties in 36 states and Washington, D.C., occupied by approximately 500 tenants, and totaling approximately 8.6 million square feet of life science and medical office properties and more than 27,000 senior living units. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $41 billion in assets under management as of December 31, 2023 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA.

Key Stats

• Today's Range: $2.47 to $2.61
• 50-Day Range: $2.47 to $4.19
• 52-Week Range: $1.97 to $4.24
• Volume: 930,226 shs
• Average Volume: 1.25 million shs
• Market Capitalization: $608.00 million
• P/E Ratio: N/A
• Dividend Yield: 1.59%
• Price Target: $4.50
• Consensus Rating: Hold

Diversified Healthcare Trust Stock Analysis - MarketRank™

Diversified Healthcare Trust scored higher than 74% of companies evaluated by MarketBeat, and ranked 389th out of 963 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

Diversified Healthcare Trust has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 1 hold rating, and 1 sell rating.

Amount of Analyst Coverage

Diversified Healthcare Trust has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 500.00%

Earnings Growth

Earnings for Diversified Healthcare Trust are expected to grow by 500.00% in the coming year, from $0.05 to $0.30 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Diversified Healthcare Trust is -1.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Diversified Healthcare Trust is -1.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Diversified Healthcare Trust has a P/B Ratio of 0.30. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.97% of the float of Diversified Healthcare Trust has been sold short.

Short Interest Ratio / Days to Cover

Diversified Healthcare Trust has a short interest ratio ("days to cover") of 6.3.

Change versus previous month

Short interest in Diversified Healthcare Trust has recently decreased by 2.74%, indicating that investor sentiment is improving.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Diversified Healthcare Trust pays a meaningful dividend of 1.59%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Diversified Healthcare Trust does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Diversified Healthcare Trust will have a dividend payout ratio of 13.33% next year. This indicates that Diversified Healthcare Trust will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.97% of the float of Diversified Healthcare Trust has been sold short.

Short Interest Ratio / Days to Cover

Diversified Healthcare Trust has a short interest ratio ("days to cover") of 6.3.

Change versus previous month

Short interest in Diversified Healthcare Trust has recently decreased by 2.74%, indicating that investor sentiment is improving.

News and Social Media

• Score: 1.8 / 5
• News Sentiment: 0.31

News Sentiment

Diversified Healthcare Trust has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Diversified Healthcare Trust this week, compared to 2 articles on an average week.

Search Interest

Only 5 people have searched for DHC on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.

MarketBeat Follows

3 people have added Diversified Healthcare Trust to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Diversified Healthcare Trust insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.37% of the stock of Diversified Healthcare Trust is held by insiders.

Percentage Held by Institutions

75.98% of the stock of Diversified Healthcare Trust is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

DHC Stock Analysis - Frequently Asked Questions

How have DHC shares performed this year?

Diversified Healthcare Trust's stock was trading at $3.74 at the beginning of 2024. Since then, DHC stock has decreased by 32.6% and is now trading at $2.52.
View the best growth stocks for 2024 here.

How were Diversified Healthcare Trust's earnings last quarter?

Diversified Healthcare Trust (NASDAQ:DHC) announced its earnings results on Monday, November, 4th. The real estate investment trust reported ($0.41) earnings per share for the quarter, missing the consensus estimate of $0.05 by $0.46. The real estate investment trust earned $373.64 million during the quarter, compared to the consensus estimate of $376.80 million. Diversified Healthcare Trust had a negative trailing twelve-month return on equity of 17.55% and a negative net margin of 26.09%.

Who are Diversified Healthcare Trust's major shareholders?

Diversified Healthcare Trust's top institutional investors include State Street Corp (2.71%), Charles Schwab Investment Management Inc. (2.70%), Geode Capital Management LLC (2.35%) and RBF Capital LLC (0.54%).
View institutional ownership trends.

How do I buy shares of Diversified Healthcare Trust?

Shares of DHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Diversified Healthcare Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Diversified Healthcare Trust investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), NVIDIA (NVDA), Ford Motor (F), AT&T (T) and Tesla (TSLA).

Company Calendar

• Ex-Dividend for 11/14 Dividend: 10/28/2024
• Last Earnings: 11/04/2024
• Dividend Payable: 11/14/2024
• Today: 11/17/2024
• Fiscal Year End: 12/31/2024
• Next Earnings (Estimated): 2/24/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Real estate investment trusts
• Sub-Industry: Specialized REITs
• Current Symbol: NASDAQ:DHC
• CUSIP: 81721M109
• CIK: 1075415
• Web: www.dhcreit.com
• Phone: (617) 796-8350
• Fax: 617-796-8349
• Employees: 600
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $4.50
• High Stock Price Target: $6.00
• Low Stock Price Target: $3.00
• Potential Upside/Downside: +78.6%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($1.61)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 50.40
• P/E Growth: N/A
• Net Income: $-293,570,000.00
• Net Margins: -26.09%
• Pretax Margin: -23.85%
• Return on Equity: -17.55%
• Return on Assets: -7.20%

Debt

• Debt-to-Equity Ratio: 1.44
• Current Ratio: 11.57
• Quick Ratio: 11.57

Sales & Book Value

• Annual Sales: $1.41 billion
• Price / Sales: 0.43
• Cash Flow: $0.01 per share
• Price / Cash Flow: 291.31
• Book Value: $8.49 per share
• Price / Book: 0.30

Miscellaneous

• Outstanding Shares: 241,270,000
• Free Float: 237,970,000
• Market Cap: $608.00 million
• Optionable: Optionable
• Beta: 2.23